# PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant

> **NCT01841333** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 31 (actual)

## Conditions studied

- Adult Acute Myeloid Leukemia in Remission
- Recurrent Adult Acute Myeloid Leukemia

## Interventions

- **DRUG:** PF-04449913

## Key facts

- **NCT ID:** NCT01841333
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-29
- **Primary completion:** 2019-05-08
- **Final completion:** 2020-02-04
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841333, "PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01841333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*